BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19582514)

  • 1. Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases.
    Fujimoto Y; Akasu T; Yamamoto S; Fujita S; Moriya Y
    J Gastrointest Surg; 2009 Sep; 13(9):1643-50. PubMed ID: 19582514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization.
    Akasu T; Moriya Y; Takayama T
    Jpn J Clin Oncol; 1997 Oct; 27(5):331-5. PubMed ID: 9390211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unresectable colorectal liver metastases: the safety and efficacy of conversion therapy using hepatic arterial infusion immunochemotherapy with 5-fluorouracil and polyethylene glycol-interferon α-2a.
    Nakai T; Okuno K; Kitaguchi H; Ishikawa H; Yamasaki M
    World J Surg; 2013 Aug; 37(8):1919-26. PubMed ID: 23564218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Takanishi K; Matsumoto J; Minami T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
    Ammori JB; Kemeny NE; Fong Y; Cercek A; Dematteo RP; Allen PJ; Kingham TP; Gonen M; Paty PB; Jarnagin WR; D'Angelica MI
    Ann Surg Oncol; 2013 Sep; 20(9):2901-7. PubMed ID: 23771246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Tono T; Takahashi H; Nakano Y; Matsushita M; Ohzato H; Fukunaga M; Watanabe H; Kanoh Y; Yasue A; Okada K; Hata T; Iwazawa T; Matsui S; Yano H; Kinuta M; Okamura J; Monden T
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1826-9. PubMed ID: 11086422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer.
    Miyanari N; Mori T; Takahashi K; Yasuno M
    Dis Colon Rectum; 2002 Nov; 45(11):1503-9. PubMed ID: 12432299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.
    Gholami S; Kemeny NE; Boucher TM; Gönen M; Cercek A; Kingham TP; Balachandran V; Allen P; DeMatteo R; Drebin J; Jarnagin W; D'Angelica M
    Ann Surg; 2020 Aug; 272(2):352-356. PubMed ID: 32675549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study.
    Tono T; Hasuike Y; Ohzato H; Takatsuka Y; Kikkawa N
    Cancer; 2000 Apr; 88(7):1549-56. PubMed ID: 10738212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
    Bolton JS; O'Connell MJ; Mahoney MR; Farr GH; Fitch TR; Maples WJ; Nagorney DM; Rubin J; Fuloria J; Steen PD; Alberts SR
    Clin Colorectal Cancer; 2012 Mar; 11(1):31-7. PubMed ID: 21729678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.
    DʼAngelica MI; Correa-Gallego C; Paty PB; Cercek A; Gewirtz AN; Chou JF; Capanu M; Kingham TP; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR; Kemeny N
    Ann Surg; 2015 Feb; 261(2):353-60. PubMed ID: 24646562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
    Lévi FA; Boige V; Hebbar M; Smith D; Lepère C; Focan C; Karaboué A; Guimbaud R; Carvalho C; Tumolo S; Innominato P; Ajavon Y; Truant S; Castaing D; De Baere T; Kunstlinger F; Bouchahda M; Afshar M; Rougier P; Adam R; Ducreux M;
    Ann Oncol; 2016 Feb; 27(2):267-74. PubMed ID: 26578731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.
    Allard MA; Sebagh M; Baillie G; Lemoine A; Dartigues P; Faitot F; Faron M; Boige V; Vitadello F; Vibert E; Elias D; Adam R; Goéré D; Sa Cunha A
    Ann Surg Oncol; 2015; 22(6):1925-32. PubMed ID: 25448804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of prophylactic hepatic arterial infusion chemotherapy after curative hepatectomy for metastatic colorectal cancer].
    Tokuoka M; Kashiwazaki M; Takeda Y; Hasuike Y; Mishima H; Ikenaga M; Masuda N; Hirao M; Fujitani K; Sawamura T; Tsujinaka T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1806-8. PubMed ID: 15553722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.